Charles K F Chan, based in Redwood City, California, is a notable inventor recognized for his significant contributions to the fields of regenerative medicine and vascular biology. With a total of three patents to his name, Chan's work focuses on therapeutic methods and compositions that enhance bone growth and vascular regeneration, particularly in patients suffering from diabetes.

Latest Patents

One of Chan's latest patents is titled "Reversing deficient hedgehog signaling restores deficient skeletal regeneration." This invention provides methods and compositions for the therapeutic use of hedgehog agents to enhance bone growth and regeneration in diabetic or pre-diabetic patients. The compositions can be administered locally, such as by injection or implantation at the site of injury, thereby facilitating repair and osseointegration of implants.

Another significant patent is "Identification and uses of vasculature forming progenitor cells and progenitor cell combinations." This invention outlines methods, compositions, and kits for producing functional blood vessels and their progenitors. It addresses human disorders of the vascular system by reconstituting functional vessels in vivo through co-transplantation with supporting niche stromal cells. This method is particularly aimed at treating ischemic injuries in the peripheral limbs and heart, with cell populations that can engraft and integrate with host vasculature to regenerate functional blood vessels.

Career Highlights

Charles K F Chan works at the esteemed Leland Stanford Junior University, where he continues to push the boundaries of medical research and innovation. His work has been instrumental in addressing critical challenges in tissue regeneration and vascular health.

Collaborations

Throughout his career, Chan has collaborated with other prominent researchers, including Michael T Longaker and Irving L Weissman. These partnerships have enriched his research and have contributed to advancements in the regenerative medicine field.

Conclusion

Charles K F Chan stands out as a pioneering inventor whose work holds the potential to transform the landscape of regenerative therapies. His innovative patents and collaborations are paving the way for enhanced treatment options for patients with skeletal and vascular deficiencies. His ongoing contributions continue to inspire future research and development within the medical community.

Profile summary based on public USPTO records.